Phase 3 Narcolepsy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been officially diagnosed with Type 1 or Type 2 Narcolepsy (based on a standard sleep disorder classification system) within the last 10 years.
• You experience excessive daytime sleepiness.
• If you are already taking certain regular medications or supplements (including some antidepressants or medications to help with wakefulness), you have been on a steady, unchanged dose for at least 3 months before the screening visit, and you are willing to keep that same dose throughout the study period.

Who may not be able to join:

• Your excessive sleepiness is caused by another medical condition rather than narcolepsy.
• You have used a medication called pitolisant recently (within a specific timeframe before screening — confirm with trial site).
• You have a primary psychiatric condition, such as depression, that has not been well-managed or stable for at least 3 months before the screening visit.
• You have ever been diagnosed with bipolar disorder or psychosis.
• You have active or long-term liver disease, or a history of moderate or severe liver damage.
• Your kidneys are not functioning well enough (based on a specific blood test measuring kidney filtration — confirm with trial site).
• You have a known history of a heart rhythm condition called Long QT Syndrome, or a serious abnormality found on a heart tracing (ECG) test.

Important: Always verify eligibility with the trial site directly before applying.